Retatrutide vs Tirzepatide vs Semaglutide: How Do They Compare?

Written by Dr. José A. Jiménez, Medical Director · Board-Certified Surgeon (UNAM) · Reviewed for medical accuracy · Last updated August 2026

Important: Semaglutide and Tirzepatide are both offered at Renovo Health and Beauty. Retatrutide is discussed here for educational purposes only and is not available as a treatment at our clinic.

If you have been researching medical weight loss, three names come up again and again: Semaglutide, Tirzepatide, and Retatrutide. They are often discussed as though they were three versions of the same thing, but they differ meaningfully in how they work, how much clinical evidence stands behind them, and whether you can actually obtain them today.

This guide explains those differences in plain language. It is written to help you understand the category, not to steer you toward a particular product. At Renovo Health and Beauty in Tijuana, Mexico, our physician-supervised weight loss program offers both Semaglutide and Tirzepatide — the sections below explain how they compare and how we determine which one fits a given patient.

Get in Touch

Send us a message and our team will get back to you shortly.

The Rise of GLP-1 and Incretin-Based Weight Loss Therapies

Semaglutide, Tirzepatide, and Retatrutide all belong to a class of medications that work by mimicking incretins — natural gut hormones that help regulate appetite, insulin response, and how the body uses energy. When these signaling pathways are supported, patients typically experience reduced hunger, earlier fullness, and improved blood sugar control.

What separates the three is how many of these pathways each one targets, and how much human clinical data exists behind it. More receptor targets does not automatically mean a better outcome for any given patient. It also means a different side effect profile and, with newer compounds, considerably less long-term safety data.

Get in Touch

Send us a message and our team will get back to you shortly.

Understanding Each Medication

Semaglutide

Semaglutide is the most established medication in this class and the one with the deepest body of published clinical evidence. It works by mimicking GLP-1 (glucagon-like peptide-1), a hormone that signals fullness, slows gastric emptying, and helps regulate insulin production.

It is recognized under brand names including Ozempic, Rybelsus, and Wegovy, and it is FDA-approved for both type 2 diabetes and chronic weight management. It has been in widespread clinical use long enough that its safety profile, dosing schedules, and side effect management are well understood by physicians.

Regulatory status: FDA-approved for type 2 diabetes and chronic weight management

Mechanism: GLP-1 receptor activation — reduces appetite, slows digestion, supports blood sugar balance

Typical weight reduction in clinical trials: roughly 10–15% of total body weight

Common side effects: mild digestive upset, nausea, or constipation — usually temporary and most noticeable during dose increases

Semaglutide is one of two medications used in Renovo Health and Beauty’s weight loss program, administered as part of a personalized plan with physician oversight, careful dose titration, and nutritional support.

Tirzepatide

Tirzepatide acts on two receptors rather than one — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual action affects both appetite regulation and how the body stores and uses fat.

It is sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for weight management), both FDA-approved. Comparative research has shown Tirzepatide producing greater average weight reduction than Semaglutide in trial settings.

Regulatory status: FDA-approved for type 2 diabetes and chronic weight management

Mechanism: dual GLP-1 and GIP receptor activation

Typical weight reduction in clinical trials: roughly 18–22% of total body weight

Common side effects: nausea, fatigue, or gastrointestinal symptoms

Tirzepatide is offered at Renovo Health and Beauty as part of our physician-supervised weight loss program. It is dispensed as an authentic, brand-name product; individual brands such as Mounjaro and Zepbound are subject to supply, but tirzepatide therapy is available regardless of which brand is in stock at a given time.

Whether Tirzepatide or Semaglutide is the better fit for you is determined during medical evaluation, based on your history, goals, and tolerance.

Retatrutide (investigational — not offered at Renovo)

Retatrutide is an investigational compound that acts on three receptors — GLP-1, GIP, and glucagon. In early trials it has produced the largest average weight reductions reported in this drug class, alongside improvements in metabolic markers.

Its status matters more than its trial numbers. Retatrutide has not received FDA approval, remains in clinical trials, and is not commercially available through legitimate pharmaceutical channels anywhere. Products sold online as “retatrutide” are unregulated research chemicals of unverified purity, potency, and sterility, and they carry real risk.

Regulatory status: not approved — investigational, in clinical trials

Mechanism: triple GLP-1, GIP, and glucagon receptor activation

Reported weight reduction in trials: up to approximately 24%

Safety data: limited; long-term profile not yet established

Retatrutide is not offered at Renovo Health and Beauty, and we do not source or administer investigational compounds. Patients genuinely interested in Retatrutide should look into enrolling in a registered clinical trial.

Side-by-Side Comparison

Feature Semaglutide Tirzepatide Retatrutide
Mechanism GLP-1 agonist Dual GLP-1 + GIP agonist Triple GLP-1, GIP + glucagon
FDA approved Yes Yes No — investigational
Avg. weight reduction (trials) 10–15% 18–22% Up to ~24%
Depth of clinical evidence Most extensive Substantial Early-stage
Primary benefit Appetite control and blood sugar support Enhanced fat loss and appetite suppression Broadest metabolic effect (under study)
Administration Weekly injection or daily oral Weekly injection Weekly (in trials)
Offered at Renovo Yes No Yes

What Actually Makes These Medications Work

The differences in mechanism matter less than most people expect, because the medication matters far less than the program built around it. Three things determine your result.

The first is physician oversight: proper candidacy screening, careful dose titration to minimize side effects, and ongoing adjustment as your body responds. The second is nutrition. Every medication in this class works by reducing appetite, but fat loss still requires a sustained calorie deficit — the medication makes that deficit achievable, and a nutrition plan makes it sustainable. The third is protecting muscle. Rapid weight loss strips lean tissue unless you actively defend it with adequate protein and resistance training, and lean muscle is the metabolically active tissue that keeps your metabolism working in your favor.

A patient on a well-managed protocol with nutritional support and muscle-preserving training will generally outperform a patient on a more aggressive compound with no structure around it.

Heading: How We Choose Between Semaglutide and Tirzepatide

Both medications are available in our program. Which one you are prescribed is a clinical decision made after evaluation, not a menu choice made in advance.

Medical history and goals. 

Tirzepatide has produced larger average weight reductions in clinical trials and is often considered for patients with more weight to lose, or for those who have plateaued on a single-pathway GLP-1. Semaglutide has the longest track record and the deepest published evidence base, which makes it a strong starting point for many patients.

retatrutide vs tirzepatide vs semaglutide 2

Tolerance and prior response. 

Gastrointestinal side effects vary between individuals and between compounds. A patient who struggled to tolerate one may do considerably better on the other, which is why titration and follow-up matter more than the initial selection.

Authenticity of supply. 

We use genuine, factory-sealed, brand-name product sourced through regulated pharmaceutical distribution channels for both medications. We do not use compounded alternatives or research-grade material. Brand availability fluctuates, and we confirm what is in stock during your consultation.

Cost and continuity of access. 

Patients treated at our Tijuana clinic frequently find both protocols substantially more affordable than U.S. retail pricing, without insurance pre-authorization requirements. Just as importantly, they can stay on a protocol continuously rather than interrupting treatment because of cost or supply gaps.

A Note on FDA Approval and Medications Sourced Abroad

Regulatory approval timelines differ between countries, and patients researching weight loss medications will encounter clinics abroad that market access to unapproved or investigational compounds as though earlier access were the benefit.

That is not our approach. Renovo Health and Beauty operates under COFEPRIS regulation in Mexico, and the medications we use are approved, brand-name pharmaceutical products.

Does Renovo Health and Beauty offer Tirzepatide, Mounjaro, or Zepbound?

Being located in Tijuana lets us offer meaningful cost advantages and shorter wait times for an established medication. It is not a mechanism for obtaining drugs that have not cleared safety review.

If a clinic offers you a compound that is still in clinical trials, treat that as a reason for caution rather than excitement.

Frequently Asked Questions

Yes. Renovo offers both Semaglutide and Tirzepatide as part of its physician-supervised weight loss program. Mounjaro and Zepbound are brand names for tirzepatide — brand availability varies with supply, but tirzepatide therapy is offered regardless of which brand is currently stocked.

No. Retatrutide is an investigational compound that has not received regulatory approval and is not commercially available. We do not source or administer it, and we would advise against obtaining it from any source that claims to sell it.

Tirzepatide activates two receptor pathways (GLP-1 and GIP) while Semaglutide activates one (GLP-1). In clinical trials Tirzepatide has produced larger average weight reductions. Semaglutide has a longer safety record and produces substantial, well-documented results for most patients.

Patients commonly report significant savings compared with U.S. out-of-pocket retail pricing, often even after accounting for travel. We provide pricing transparently during your consultation.

Yes. Both Semaglutide and Tirzepatide are approved for chronic weight management in adults with obesity or weight-related health conditions, independent of diabetes status. Candidacy is determined through medical evaluation.

No. We use authentic, factory-sealed, brand-name product sourced through regulated distribution channels for both Semaglutide and Tirzepatide.

Medical evaluation and candidacy screening, personalized dose titration, nutritional guidance, and ongoing follow-up. The medication is one component of the program, not the whole of it.

This content is for informational purposes only and is not a substitute for individualized medical advice. Results vary by patient. Candidacy for any weight loss medication is determined through medical evaluation. Renovo Health and Beauty — COFEPRIS Reg. No. 2402022002A00037.

Renovo HB - WL eBook Section

Sign up for our free eBook